Related references
Note: Only part of the references are listed.Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
So Young Kang et al.
DIAGNOSTIC PATHOLOGY (2013)
Molecular pathogenesis and mechanisms of thyroid cancer
Mingzhao Xing
NATURE REVIEWS CANCER (2013)
Correlation between BRAF mutation and promoter methylation of TIMP3, RARβ2 and RASSF1A in thyroid cancer
Mariana Brait et al.
EPIGENETICS (2012)
Association of promoter methylation with histologic type and pleural indentation in non-small cell lung cancer (NSCLC)
Meiju Ji et al.
DIAGNOSTIC PATHOLOGY (2011)
Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China
Qingbin Song et al.
DIAGNOSTIC PATHOLOGY (2011)
Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells
Peng Hou et al.
ENDOCRINE-RELATED CANCER (2011)
Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules
Husain A. Saleh et al.
DIAGNOSTIC PATHOLOGY (2010)
Prognostic utility of BRAF mutation in papillary thyroid cancer
Mingzhao Xing
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions
Dada Handkiewicz-Junak et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
Adrienne L. Melck et al.
ONCOLOGIST (2010)
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies
Maria Chiara Zatelli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid Nodules
Yuri E. Nikiforov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Molecular Diagnostics and Predictors in Thyroid Cancer
Marina N. Nikiforova et al.
THYROID (2009)
BRAF mutation in papillary thyroid cancer:: Pathogenic role, molecular bases, and clinical implications
Mingzhao Xing
ENDOCRINE REVIEWS (2007)
Minireview: Gene methylation in thyroid tumorigenesis
Mingzhao Xing
ENDOCRINOLOGY (2007)
Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer
Shuiying Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAFV600E mutation-prevalent area
Ki-Wook Chung et al.
CLINICAL ENDOCRINOLOGY (2006)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Detection of serum deoxyribonucleic acid methylation markers: A novel diagnostic tool for thyroid cancer
SY Hu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis
J. E. Barroeta et al.
ENDOCRINE PATHOLOGY (2006)
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors
N Nakamura et al.
LABORATORY INVESTIGATION (2005)
Quantitative assessment of promoter methylation profiles in thyroid neoplasms
MO Hoque et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
ML Prasad et al.
MODERN PATHOLOGY (2005)
Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis
MZ Xing et al.
CANCER RESEARCH (2004)
Molecular detection of thyroid cancer: an update
J Bojunga et al.
CLINICAL ENDOCRINOLOGY (2004)
Detection of BRAF mutation on fine needle aspiration biopsy specimens:: A new diagnostic tool for papillary thyroid cancer
MZ Xing et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents
M Niedziela et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management
P Werga et al.
WORLD JOURNAL OF SURGERY (2000)
Share Paper
